Br Med J (Clin Res Ed)  1986;293:1121-1126 (1 November), doi:10.1136/bmj.293.6555.1121

Effect of optimal glycaemic control with continuous subcutaneous insulin infusion on energy expenditure in type I diabetes mellitus.

P Leslie, R T Jung, T E Isles, J Baty, R W Newton, P Illingworth

To assess the role of insulin in the control of body weight energy expenditure was measured by indirect calorimetry in eight patients of normal weight with type I diabetes initially while poorly controlled during conventional insulin treatment and later during optimal glycaemic control achieved by using the continuous subcutaneous insulin infusion pump. Their response to seven days of fat supplementation was also assessed and the results compared with those in eight non-diabetic subjects. After a mean of 5.3 months of continuous subcutaneous insulin infusion the diabetic subjects had gained on average 3.5 kg. In the poorly controlled diabetic state the resting metabolic rate was raised but decreased by a mean of 374 kJ (90 kcal) per 24 hours with optimal glycaemic control. The thermic response to infused noradrenaline was reduced by 59% in the diabetic subjects, was not improved by continuous subcutaneous insulin infusion, but was improved when three of the subjects were given metformin in addition. The diabetic subjects had no abnormality in the thermic response to a meal while taking their usual diabetic diet. During fat supplementation, however, this thermic response was reduced when glycaemic control was poor but not when control was precise. Fat supplementation did not alter the resting metabolic rate or the reduced noradrenergic thermic response in the diabetic subjects. These findings suggest that precise glycaemic control could produce weight gain if energy intake remained unaltered, for diabetic subjects do not compensate for the decrease in metabolic rate by an increase in noradrenergic and dietary thermic responses. Also precise glycaemic control using continuous subcutaneous insulin infusion does not correct all the metabolic abnormalities of diabetes mellitus.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Richardson, T., Kerr, D. (2003). Obesity in type 2 diabetes -- local experience in a district general hospital. British Journal of Diabetes & Vascular Disease 3: 49-52 [Abstract]  
  • Wollersheim, H., Netten, P.M., Lutterman, J.A., Lenders, J.W.M. (1989). Ephedrine Improves Microcirculation in the Diabetic Neuropathic Foot. ANGIOLOGY 40: 1030-1034 [Abstract]  
  • Hernandez, C. G. (1989). The Pathophysiology of Diabetes Mellitus: An Update. The Diabetes Educator 15: 162-169  
Access jobs at BMJ Careers
Whats new online at Student BMJ